Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

346 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
PI3K: from the bench to the clinic and back.
Vanhaesebroeck B, Vogt PK, Rommel C. Vanhaesebroeck B, et al. Among authors: vogt pk. Curr Top Microbiol Immunol. 2010;347:1-19. doi: 10.1007/82_2010_65. Curr Top Microbiol Immunol. 2010. PMID: 20549473 Free PMC article. Review.
Phosphatidylinositol 3-kinase: the oncoprotein.
Vogt PK, Hart JR, Gymnopoulos M, Jiang H, Kang S, Bader AG, Zhao L, Denley A. Vogt PK, et al. Curr Top Microbiol Immunol. 2010;347:79-104. doi: 10.1007/82_2010_80. Curr Top Microbiol Immunol. 2010. PMID: 20582532 Free PMC article. Review.
PI3K and STAT3: a new alliance.
Vogt PK, Hart JR. Vogt PK, et al. Cancer Discov. 2011 Nov;1(6):481-6. doi: 10.1158/2159-8290.CD-11-0218. Cancer Discov. 2011. PMID: 22348200 Free PMC article. Review.
Retroviral oncogenes and TOR.
Aoki M, Vogt PK. Aoki M, et al. Among authors: vogt pk. Curr Top Microbiol Immunol. 2004;279:321-38. doi: 10.1007/978-3-642-18930-2_19. Curr Top Microbiol Immunol. 2004. PMID: 14560966 Review.
Class I PI3K in oncogenic cellular transformation.
Zhao L, Vogt PK. Zhao L, et al. Among authors: vogt pk. Oncogene. 2008 Sep 18;27(41):5486-96. doi: 10.1038/onc.2008.244. Oncogene. 2008. PMID: 18794883 Free PMC article. Review.
PF-04691502, a potent and selective oral inhibitor of PI3K and mTOR kinases with antitumor activity.
Yuan J, Mehta PP, Yin MJ, Sun S, Zou A, Chen J, Rafidi K, Feng Z, Nickel J, Engebretsen J, Hallin J, Blasina A, Zhang E, Nguyen L, Sun M, Vogt PK, McHarg A, Cheng H, Christensen JG, Kan JL, Bagrodia S. Yuan J, et al. Among authors: vogt pk. Mol Cancer Ther. 2011 Nov;10(11):2189-99. doi: 10.1158/1535-7163.MCT-11-0185. Epub 2011 Jul 12. Mol Cancer Ther. 2011. PMID: 21750219
Kinase inhibitors: vice becomes virtue.
Vogt PK, Kang S. Vogt PK, et al. Cancer Cell. 2006 May;9(5):327-8. doi: 10.1016/j.ccr.2006.05.002. Cancer Cell. 2006. PMID: 16697951 Free article.
PI 3-kinase and cancer: changing accents.
Vogt PK, Gymnopoulos M, Hart JR. Vogt PK, et al. Curr Opin Genet Dev. 2009 Feb;19(1):12-7. doi: 10.1016/j.gde.2008.11.011. Curr Opin Genet Dev. 2009. PMID: 19185485 Free PMC article. Review.
346 results